
Aptol Pharma is a biotechnology platform company which aims to develop first-in-class functional cures for a broad range of autoimmune diseases via our proprietary peptide-nanoparticle technology. Four founders of the company together with our BoD strive to make our first asset APT001 for rheumatoid arthritis Phase 1 ready in 2025: Founders: Kira Astakhova: Ass. Professor at DTU, Expert in the aptamer technology development Mads Clausen - Professor at DTU and expert in bioorganic chemistry Tue Wenzel Kragstrup - Rheumatology specialist, Clinician Mark Daniel Zalomajev - marketing and business…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.